These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25410816)
1. FTIR spectroscopic study of poly(ethylene glycol)-nifedipine dispersion stability in different relative humidities. Iqbal WS; Chan KL J Pharm Sci; 2015 Jan; 104(1):280-4. PubMed ID: 25410816 [TBL] [Abstract][Full Text] [Related]
2. FTIR spectroscopic imaging of dissolution of a solid dispersion of nifedipine in poly(ethylene glycol). Chan KL; Kazarian SG Mol Pharm; 2004; 1(4):331-5. PubMed ID: 15981592 [TBL] [Abstract][Full Text] [Related]
3. Characterization and stability of solid dispersions based on PEG/polymer blends. Bley H; Fussnegger B; Bodmeier R Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875 [TBL] [Abstract][Full Text] [Related]
4. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy. Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042 [TBL] [Abstract][Full Text] [Related]
5. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions. Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691 [TBL] [Abstract][Full Text] [Related]
6. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging. Ewing AV; Clarke GS; Kazarian SG Eur J Pharm Sci; 2014 Aug; 60():64-71. PubMed ID: 24832964 [TBL] [Abstract][Full Text] [Related]
7. Solid-state characterization of nifedipine solid dispersions. Vippagunta SR; Maul KA; Tallavajhala S; Grant DJ Int J Pharm; 2002 Apr; 236(1-2):111-23. PubMed ID: 11891075 [TBL] [Abstract][Full Text] [Related]
8. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage. Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761 [TBL] [Abstract][Full Text] [Related]
9. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels. Zahedi P; Lee PI Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231 [TBL] [Abstract][Full Text] [Related]
10. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution. Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532 [TBL] [Abstract][Full Text] [Related]
11. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method. Kushida I; Gotoda M Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663 [TBL] [Abstract][Full Text] [Related]
12. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Rumondor AC; Marsac PJ; Stanford LA; Taylor LS Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917 [TBL] [Abstract][Full Text] [Related]
13. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage. Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260 [TBL] [Abstract][Full Text] [Related]
14. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers. Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546 [TBL] [Abstract][Full Text] [Related]
15. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA. Wlodarski K; Sawicki W; Kozyra A; Tajber L Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119 [TBL] [Abstract][Full Text] [Related]
16. Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG₆₀₀₀ for compacted oral formulations. Soulairol I; Tarlier N; Bataille B; Cacciaguerra T; Sharkawi T Int J Pharm; 2015 Mar; 481(1-2):140-7. PubMed ID: 25579869 [TBL] [Abstract][Full Text] [Related]
18. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. Aso Y; Yoshioka S; Kojima S J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195 [TBL] [Abstract][Full Text] [Related]
19. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water. Marsac PJ; Konno H; Rumondor AC; Taylor LS Pharm Res; 2008 Mar; 25(3):647-56. PubMed ID: 17846870 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of a solid phase reaction among excipients that accelerates drug release from a solid dispersion with aging. Mizuno M; Hirakura Y; Yamane I; Miyanishi H; Yokota S; Hattori M; Kajiyama A Int J Pharm; 2005 Nov; 305(1-2):37-51. PubMed ID: 16226411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]